New Delhi [India], April 21 (ANI): A four-month-old COVID-19 patient baby admitted to the hospital here is on oxygen support, if the parents do not take the vaccine, then their children are at risk, said the Medical Director of Lok Nayak Hospital, Dr Suresh Kumar.
Beijing [China], April 18 (ANI): Producers of Chinese herbal medicine, which has been widely used to treat COVID-19 patients and being distributed to Shanghai residents, are facing a heavy blow to its reputation after an influential health platform said on Sunday that the famous medicine can
New Delhi [India], March 5 (ANI/Target Media): In a landmark development for the treatment of COVID-19, Themis Medicare Ltd. (Themis), a Pharmaceutical company headquartered in Mumbai with a legacy of over 50 years of making new treatment options available, announced the approval of its a
Massachusetts [US], February 28 (ANI): Many people have complained recently about being diagnosed with diabetes after contracting and recovering from COVID-19. A study by the Massachusetts General Hospital (MGH) has found that many COVID-19 patients, newly diagnosed with diabetes during hosp
New Delhi [India], February 9 (ANI): Mumbai based innovation-driven global pharma company Glenmark has launched Nitric Oxide Nasal Spray (FabiSpray) in India, in partnership with SaNOtize, for treatment of adult patients suffering from COVID-19.
Washington [US], February 5 (ANI): A new study has found that low levels of vitamin D are associated with severe cases of COVID-19 as well as mortality.
New York [US], February 4 (ANI): A recent study has found that the brains of a small sample of patients who died of COVID-19 displayed some of the same molecular changes found in the brains of people with Alzheimer's disease.
Washington [US], February 3 (ANI): A new research has found that a combined treatment strategy targeting SARS-CoV-2 symptoms and severe lung tissue injury is essential to minimize lung sequelae -- chronic complications resulting from COVID-19 infection.
Washington [US], January 30 (ANI): The combination of remdesivir plus a highly concentrated solution of antibodies that neutralize SARS-CoV-2 is not more effective than remdesivir alone for treating adults hospitalised with COVID-19, according to recent research.
Washington [US], January 28 (ANI): A new study has found that the combination of remdesivir plus a highly concentrated solution of antibodies that neutralize SARS-CoV-2 is not more effective than remdesivir alone for treating adults hospitalised with COVID-19.
Amaravati (Andhra Pradesh) [India], January 25 (ANI): Following the rise in COVID-19 infections, the NTR Memorial Trust has begun extensive 'telemedicine' services for the Covid-19 patients, said a press release.